Data as of 2:45pm ET
| -0.078 / -2.64%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.75, with a high estimate of 8.74 and a low estimate of 6.76. The median estimate represents a +169.02% increase from the last price of 2.88.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.